WO2003012103A3 - Acides nucleiques codant de nouvelles proteines a boite f, leurs utilisations en diagnostic et en therapie - Google Patents

Acides nucleiques codant de nouvelles proteines a boite f, leurs utilisations en diagnostic et en therapie Download PDF

Info

Publication number
WO2003012103A3
WO2003012103A3 PCT/FR2002/002783 FR0202783W WO03012103A3 WO 2003012103 A3 WO2003012103 A3 WO 2003012103A3 FR 0202783 W FR0202783 W FR 0202783W WO 03012103 A3 WO03012103 A3 WO 03012103A3
Authority
WO
WIPO (PCT)
Prior art keywords
novel
fbox
diagnostic
nucleic acids
therapeutic uses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR2002/002783
Other languages
English (en)
Other versions
WO2003012103A2 (fr
Inventor
Dominique Thomas
Bruno Sargueil
Frederic Scaerou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cytomics Systems
Original Assignee
Cytomics Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytomics Systems filed Critical Cytomics Systems
Priority to AU2002337248A priority Critical patent/AU2002337248A1/en
Publication of WO2003012103A2 publication Critical patent/WO2003012103A2/fr
Anticipated expiration legal-status Critical
Publication of WO2003012103A3 publication Critical patent/WO2003012103A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La présente invention a pour objet de nouvelles protéines Fbox et de nouveaux substrats des protéines Fbox. Elle a pour objet les méthodes de criblage mise au point pour identifier les substrats des nouvelles protéines Fbox et pour identifier les petites molécules et drogues qui modulent l'interaction et/ou l'activité des protéines Fbox et de leurs substrats.
PCT/FR2002/002783 2001-08-01 2002-08-01 Acides nucleiques codant de nouvelles proteines a boite f, leurs utilisations en diagnostic et en therapie Ceased WO2003012103A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002337248A AU2002337248A1 (en) 2001-08-01 2002-08-01 Nucleic acids coding for novel fbox proteins, their diagnostic and therapeutic uses

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0110363 2001-08-01
FR0110363A FR2828208A1 (fr) 2001-08-01 2001-08-01 Acides nucleiques codant de nouvelles proteines a boite f, leurs utilisations en diagnostic et en therapie

Publications (2)

Publication Number Publication Date
WO2003012103A2 WO2003012103A2 (fr) 2003-02-13
WO2003012103A3 true WO2003012103A3 (fr) 2004-04-22

Family

ID=8866215

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2002/002783 Ceased WO2003012103A2 (fr) 2001-08-01 2002-08-01 Acides nucleiques codant de nouvelles proteines a boite f, leurs utilisations en diagnostic et en therapie

Country Status (3)

Country Link
AU (1) AU2002337248A1 (fr)
FR (1) FR2828208A1 (fr)
WO (1) WO2003012103A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060088846A1 (en) * 1998-08-28 2006-04-27 Michele Pagano Methods to identify compounds useful for the treatment of proliferative and differentiative disorders
AUPR278301A0 (en) 2001-01-31 2001-02-22 Bionomics Limited A novel gene
BR112012019902A2 (pt) * 2010-02-10 2019-09-24 Novartis Ag "método e compostos para o crescimento muscular"
CN102382829B (zh) * 2011-05-03 2013-06-26 中国人民解放军军事医学科学院放射与辐射医学研究所 Fbxl15蛋白抑制剂以及它们的应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995011995A1 (fr) * 1993-10-26 1995-05-04 Affymax Technologies N.V. Reseaux de sondes d'acide nucleique sur des microplaquettes biologiques
WO1999018989A1 (fr) * 1997-10-16 1999-04-22 Baylor College Of Medicine Proteines et genes a sequence f
WO2000012679A1 (fr) * 1998-08-28 2000-03-09 New York University Nouvelles ubiquitine ligases utiles comme cibles therapeutiques
WO2000075184A1 (fr) * 1999-06-04 2000-12-14 Yale University Modulation de taux de proteines au moyen du complexe scf

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995011995A1 (fr) * 1993-10-26 1995-05-04 Affymax Technologies N.V. Reseaux de sondes d'acide nucleique sur des microplaquettes biologiques
WO1999018989A1 (fr) * 1997-10-16 1999-04-22 Baylor College Of Medicine Proteines et genes a sequence f
WO2000012679A1 (fr) * 1998-08-28 2000-03-09 New York University Nouvelles ubiquitine ligases utiles comme cibles therapeutiques
WO2000075184A1 (fr) * 1999-06-04 2000-12-14 Yale University Modulation de taux de proteines au moyen du complexe scf

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CENCIARELLI C ET AL: "IDENTIFICATION OF A FAMILY OF HUMAN F-BOX PROTEINS", CURRENT BIOLOGY, vol. 9, 1999, pages 1177 - 1179, XP000953487, ISSN: 0960-9822 *
CRAIG K L ET AL: "THE F-BOX: A NEW MOTIF FOR UBIQUITIN DEPENDENT PROTEOLYSIS IN CELL CYCLE REGULATION AND SIGNAL TRANSDUCTION", PROGRESS IN BIOPHYSICS AND MOLECULAR BIOLOGY, PERGAMON PRESS, OXFORD, GB, vol. 72, no. 3, 1999, pages 299 - 328, XP001024962, ISSN: 0079-6107 *
DATABASE EMBL [online] 29 September 2000 (2000-09-29), XP002201883, Database accession no. AK026541 *

Also Published As

Publication number Publication date
AU2002337248A1 (en) 2003-02-17
FR2828208A1 (fr) 2003-02-07
WO2003012103A2 (fr) 2003-02-13

Similar Documents

Publication Publication Date Title
WO1999053061A3 (fr) Acides nucleiques associes a des tumeurs et leur emploi
WO2002099055A3 (fr) Cip comme modificateurs de la voie p53 et methodes d'utilisation associees
WO2003016475A3 (fr) Sequences d'acides nucleiques et d'acides amines intervenant dans la douleur
AU7494701A (en) Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
AU2002258518A1 (en) Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
WO2002095051A3 (fr) Peptides mage-a3 presentes par des molecules hla de classe ii
WO2002061060A3 (fr) Proteines kinases humaines isolees, molecule d'acide nucleique codant ces proteines kinases humaines et leurs utilisations
WO2002008285A3 (fr) Molecules il-17 et leurs utilisations
ATE394484T1 (de) Smad 6 und dessen anwendungen
WO2004092210A3 (fr) Molecule
WO2002065134A3 (fr) Procedes et agents de criblage
WO2004113500A3 (fr) B7s1: modulateur immun
WO2003027251A3 (fr) Nouvelles molecules de la famille des proteines du domaine de pyrine et leur utilisation
WO2003012103A3 (fr) Acides nucleiques codant de nouvelles proteines a boite f, leurs utilisations en diagnostic et en therapie
WO2002026929A3 (fr) Proteine moteur kini-3 et methodes d'utilisation associees
WO2003012102A3 (fr) Acides nucleiques codant des proteines a domaine hect
PL374550A1 (en) Il-17 like molecules and uses thereof
WO2001074903A3 (fr) Molecules du type recepteur de cd20/ige et leurs applications
WO2003070965A8 (fr) Promoteur eaat2 et utilisations de ce promoteur
WO2002031115A3 (fr) Molecules d'acide nucleique et polypeptides aux fins d'une immunomodulation
WO2004047758A3 (fr) Methodes therapeutiques et diagnostiques mettant en application le ciblage de cellules exprimant p2y10
WO2004007536A3 (fr) Nouvelles interactions de la proteine du virus d'epstein-barr ebna1, compositions et methodes associees
WO2002059149A3 (fr) Proteines pro-apoptotiques et molecules d'adn les codant
DE60120187D1 (de) Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen
WO2004035733A3 (fr) Proteines hepsine/46 humaines isolees, molecules d'acide nucleique codant les proteines hepsine/46, et utilisations associees

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP